Torrent Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on March 23, 2016, has decided to obtain enabling approvals, from the shareholders, for issuance of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes for an amount not exceeding Rs 3,000 crores: and Unsecured / Secured Redeemable Non-Convertible Debentures / Bonds by way of Private Placement for an amount not exceeding Rs 7,500 crores, subject to the overall borrowing limits of Rs 10,000 crores securities through postal ballot process. The Board meeting commenced at 11:00 A.M. and concluded at 12:00 Noon. A Press release on the issuance of Securities is enclosed herewith.
The above information is a part of company’s filings submitted to BSE.
